Cisbio releases a new HTRF assay offer dedicated to the cGas/STING pathway.

Cisbio announces the launch of 3 novel HTRF STING assays
Cisbio extends its assay portfolio for immuno-oncology drug discovery with breakthrough biochemical and cell-based STING assays.
Get the press release